References
1. Babalola O., Gebben D., Tarver M.E., Sangha R., Roberts J., Price V. Patient preferences regarding surgical treatment methods for symptomatic uterine fibroids. Ther Innov Regul Sci. 2023; 57 (5): 976–86.
2. Giuliani E., As-Sanie S., Marsh E.E. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020; 149 (1): 3–9.
3. Li B., Wang F., Chen L., Tong H. Global epidemiological characteristics of uterine fibroids. Arch Med Sci. 2023; 19 (6): 1802–10.
4. Rezk A., Kahn J., Singh M. Fertility Sparing Management in Uterine Fibroids. StatPearls Publishing, 2024. URL: http://www.ncbi.nlm.nih.gov/books/NBK574504/
5. Uimari O., Subramaniam K.S., Vollenhoven B., Tapmeier T.T. Uterine fibroids (Leiomyomata) and heavy menstrual bleeding. Front Reprod Health. 2022; 4: 818243.
6. Stewart E.A., Nowak R.A. Uterine fibroids: hiding in plain sight. Physiology (Bethesda). 2022; 37 (1): 16–27.
7. Yan W., Yuan S., Zhou D., Zhang M., Yang S., Wang W., et al. Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021. BMJ Open. 2024; 14 (1): e081736.
8. Leyland N., Leonardi M., Murji A., Singh S.S., Al-Hendy A., Bradley L. A call-to-action for clinicians to implement evidence-based best practices when caring for women with uterine fibroids. Reprod Sci. 2022; 29 (4): 1188–96.
9. Cianci S., Gulino F.A., Palmara V., La Verde M., Ronsini C., Romeo P. et al. Exploring surgical strategies for uterine fibroid treatment: a comprehensive review of literature on open and minimally invasive approaches. Medicina (Kaunas). 2023; 60 (1): 64.
10. Çinar M., Tokmak A., Güzel A.I., Aksoy R.T., Özer İ., Yilmaz N. et al. Association of clinical outcomes and complications with obesity in patients who have undergone abdominal myomectomy. J Chin Med Assoc. 2016; 79 (8): 435–9.
11. Reschke L., Afrin S., El Sabah M., Charewycz N., Miyashita-Ishiwata M, Borahay M.A. Leptin induces leiomyoma cell proliferation and extracellular matrix deposition via JAK2/STAT3 and MAPK/ERK pathways. F S Sci. 2022; 3 (4): 383–91.
12. Radynova S.B., Kenyaykina A.G., Lodyreva M.S., Turaeva M.A. The analysis of the main indications for surgical treatment of a uterine myoma for women with safe menstrual function. Sinergiya nauk [Synergy of Sciences]. 2019; (32): 1167–73. EDN VVIUSF. (in Russian)
13. Cao H., Li L., Yang B., Luo G., Lou J., Xi M. Unexpected uterine sarcomas after hysterectomy and myomectomy for presumed leiomyoma: a retrospective study of 26,643 patients. Cancer Manag Res. 2019; 11: 7007–74.